We are live on ! Find out more
SLG

Stanley-Laman Group Portfolio holdings

AUM $814M
1-Year Est. Return 40.24%
This Fund
S&P 500
This Quarter Est. Return
+3.34%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$244M
AUM Growth
-$11.5M
Cap. Flow
-$17.8M
Cap. Flow %
-7.28%
Top 10 Hldgs %
27.75%
Holding
287
New
30
Increased
69
Reduced
110
Closed
41

Top Buys

Rank Stock Value
1
MON
Monsanto Co
MON
+$14.6M
2
DIS icon
Walt Disney
DIS
+$10.3M
3
GILD icon
Gilead Sciences
GILD
+$10.2M
4
ABBV icon
AbbVie
ABBV
+$9.79M
5
NLSN
Nielsen Holdings plc
NLSN
+$4.28M

Top Sells

Rank Stock Value
1
CXW icon
CoreCivic
CXW
+$6.9M
2
GEO icon
The GEO Group
GEO
+$6.36M
3
MDU icon
MDU Resources
MDU
+$6.33M
4
SBRA icon
Sabra Healthcare REIT
SBRA
+$5.72M
5
CNA icon
CNA Financial
CNA
+$5.55M

Sector Composition

Rank Sector Weight
1 Healthcare 19.36%
2 Communication Services 10.2%
3 Technology 10.03%
4 Industrials 8.75%
5 Materials 8.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RDS.A
276
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
-3,779
Closed -$209K
SHLM
277
DELISTED
Schulman (A.) Inc
SHLM
-118,082
Closed -$2.88M
SE
278
DELISTED
Spectra Energy Corp Wi
SE
-28,230
Closed -$1.03M
IHS
279
DELISTED
IHS INC CL-A COM STK
IHS
-8,907
Closed -$1.03M
RAS
280
DELISTED
RAIT Financial Trust
RAS
-12,000
Closed -$38K
SHPG
281
DELISTED
Shire pic
SHPG
-1,185
Closed -$218K

Similar funds

Stanley-Laman Group's Q3 2016 Portfolio in Review

As of Q3 2016, Stanley-Laman Group held 287 positions worth $244M, down 4.5% from $256M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Stanley-Laman Group withdrew a net $17.8M in Q3 2016, closing 41 positions and reducing 110 holdings. Its most notable exit was CoreCivic, an estimated $6.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 11% a quarter earlier, followed by Communication Services and Technology.

Against the trend, Stanley-Laman Group opened a new position in Monsanto Co worth $14.3M.

  • Stanley-Laman Group's largest Q3 2016 buy was Monsanto Co: 139,510 shares worth $14.3M.
  • Stanley-Laman Group added most to Gilead Sciences in Q3 2016, an estimated $10.2M increase.
  • Stanley-Laman Group's biggest Q3 2016 reduction was Sabra Healthcare REIT, cutting an estimated $5.72M.
  • Stanley-Laman Group fully exited CoreCivic in Q3 2016, selling an estimated $6.9M.
  • Stanley-Laman Group's ten largest holdings make up 28% of its $244M portfolio in Q3 2016.
  • Stanley-Laman Group opened 30 new positions and closed 41 in Q3 2016.
  • Stanley-Laman Group's portfolio value fell 4.5% quarter-over-quarter to $244M.

Based on Stanley-Laman Group's 13F filing for Q3 2016, filed 28 Oct 2016.